Interaction of 2-formylpyridine thiosemicarbazonato copper (II) with Ehrlich ascites tumor cells.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D001693:Biological Transport, Active; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005978:Glutathione / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D009942:Organometallic Compounds / Q000378:metabolism*; D010101:Oxygen Consumption; D011725:Pyridines / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009942:Organometallic Compounds; D011725:Pyridines; D013438:Sulfhydryl Compounds; C031471:2-formylpyridine thiosemicarbazonato copper(II); D005978:Glutathione; D013936:Thymidine; D014529:Uridine